Women's Health

Clinical Trials

View:

Clinical Trials
found within the Condition / Disease = "Women's Health"

(click the Trial Title link to see detailed information about that Trial)

Title	Sub Themes	Location
N063D/BIG 2-06, ALTTO: Adjuvant Lapatinib and/or Trastuzumab Treatment Optimisation Study - A randomised, multi-centre, open-label,phase III study of adjuvant lapatinib, trastuzumab, their sequence and their combination in patients with HER2/ErbB2 positive primary breast cancer	Women's Health	Minnesota Florida Arizona
06-213 A Phase 2 Study of Lapatinib (Tykerb) in Combination with Trastuzumab (Herceptin) in Patients with HER2-Positive, Metastatic Breast Cancer	Women's Health	Minnesota
A Molecular Staging Study of Endometrial Cancer (GOG 0210)	Women's Health	Minnesota Florida Arizona
A Phase II Trial of Gemcitabine (Gemzar) in combination with 17-Allylaminogeldanamycin (17AAG) (Tanespimycin) in Advanced Epithelial Ovarian and Primary Peritoneal Cancer	Women's Health	Minnesota Florida Arizona
Bisphosphonates as Treatment in Breast Cancer (S0307)	Women's Health	Minnesota Florida Arizona
Combined Chemotherapy and Hormone Therapy for Individuals with a Low Risk of Cancer Recurrence after Ten Years: The TAILORx Trial	Women's Health	Minnesota Florida
Comparison of Types of Radiation Techniques for Women with Early Stages of Breast Cancer (B-39)	Women's Health	Minnesota Florida
Estrogen-DNA Adducts in Breast, Urine and Serum (Blood) as Biomarkers of Breast Cancer Risk	Women's Health	Minnesota
Evaluating the Role of Exemestane Plus GnRH Analogue as Adjuvant Therapy for Premenopausal Women with Endocrine Responsive Breast Cancer (IBCSG 25-02)	Women's Health	Minnesota Florida
Evaluating the Role of Ovarian Function Suppression and the Role of Exemestane Adjuvant Therapies for Pre-Menopausal Women with Endocrine Responsive Breast Cancer (IBCSG 24-02)	Women's Health	Minnesota
Flavopiridol and Cisplatin in Advanced Epithelial Ovarian and Primary Peritoneal Cancers (MC0261)	Women's Health	Minnesota Florida Arizona
Genetics Study for Women with Breast Cancer and Starting Anastrozole (Arimidex) Treatment (MC0532)	Women's Health	Minnesota Florida
GOG-0215, A Phase 2 Study Evaluating Bone Mineral Density in Individuals Having Removal of the Ovaries to Prevent Ovarian Cancer, Receiving Either Zoledronic Acid (Zometa) or Observation	Women's Health	Minnesota
GOG-0219, A Phase III, Randomized Study of Weekly Cisplatin and Radiation versus Cisplatin and Tirapazamine (IND #46525) and Radiation in Stage IB2, IIA, IIB, IIIB and IVA Cervical Cancer Limited to the Pelvis	Women's Health	Minnesota Florida
Phase 3 Trial of Maintenance Chemotherapy Comparing 12, Monthly Cycles of Paclitaxel or Xyotax (CT-2103) (IND#70177), Versus No Treatment Until Documented Relapse In Women with Advanced Ovarian or Primary Peritoneal Cancer Who Achieve A Complete Clinical Response to Primary Platinum/Taxane Chemotherapy	Women's Health	Minnesota Florida Arizona
Phase III Study of Cyclophosphamide (Cytoxan) and Doxorubicin (Adriamycin) (CA) (4 Cycles) Versus Paclitaxel (Taxol) (4 Cycles) as Adjuvant Therapy for Breast Cancer in Women with 0-3 Positive Axillary Lymph Nodes	Women's Health	Minnesota Florida
Quality of Life Study about Religious and Spiritual Activities Used as Coping Resources for Women with Advanced Ovarian, Primary Peritoneal, Fallopian Tube, or Early Stage Endometrial Cancer	Women's Health	Minnesota Arizona
Treatment with Examestane, an Aromatase Inhibitor, versus Placebo, for Postmenopausal Women at High Risk for Developing Breast Cancer (MAP 3)	Women's Health	Minnesota
Trial of Intraperitoneal Administration of a CEA-Expressing Derivative Manufactured from a Genetically Engineered Strain of Measles Virus in Patients with Recurrent Ovarian Cancer (MC0117)	Women's Health	Minnesota

Legal restrictions and terms of use applicable to this site
Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.